Preventing graft re-JAK-tion: safer transplant conditioning enables murine islet allograft tolerance and diabetes reversal
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci201105 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Stephen P Persaud und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Laboratory and Genomic Medicine, Department of Pathology & Immunology, and. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Transplantation Conditioning, Diabetes Mellitus, Type 1, Transplantation Tolerance. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Laboratory and Genomic Medicine, Department of Pathology & Immunology, and.
- Section of Cellular Therapy, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
Zitieren
APA
Persaud, S. P., & DiPersio, J. F. (2026). Preventing graft re-JAK-tion: safer transplant conditioning enables murine islet allograft tolerance and diabetes reversal. Journal of Clinical Investigation. https://doi.org/10.1172/jci201105
Vancouver
Persaud SP, DiPersio JF. Preventing graft re-JAK-tion: safer transplant conditioning enables murine islet allograft tolerance and diabetes reversal. Journal of Clinical Investigation. 2026. doi:10.1172/jci201105
BibTeX
@article{Persaud2026,
author = {Persaud, Stephen P and DiPersio, John F},
title = {Preventing graft re-JAK-tion: safer transplant conditioning enables murine islet allograft tolerance and diabetes reversal},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci201105}
}
EUVIMED